Cargando…

An Up-to-Date Overview of the Complexity of Genotype-Phenotype Relationships in Myotonic Channelopathies

Myotonic disorders are inherited neuromuscular diseases divided into dystrophic myotonias and non-dystrophic myotonias (NDM). The latter is a group of dominant or recessive diseases caused by mutations in genes encoding ion channels that participate in the generation and control of the skeletal musc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morales, Fernando, Pusch, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978732/ https://www.ncbi.nlm.nih.gov/pubmed/32010054 http://dx.doi.org/10.3389/fneur.2019.01404

Ejemplares similares

Genotype-Phenotype Correlations and Characterization of Medication Use in Inherited Myotonic Disorders
por: Meyer, Alayne P., et al.
Publicado: (2020)

Combinatorial chloride and calcium channelopathy in myotonic dystrophy
por: Cisco, Lily A., et al.
Publicado: (2023)

SCN1A channelopathies: Navigating from genotype to neural circuit dysfunction
por: Bryson, Alexander, et al.
Publicado: (2023)

Autoimmune Channelopathies at Neuromuscular Junction
por: Huang, Kun, et al.
Publicado: (2019)

Modeling of Myotonic Dystrophy Cardiac Phenotypes in Drosophila
por: Chakraborty, Mouli, et al.
Publicado: (2018)

Case report: Sodium and chloride muscle channelopathy coexistence: A complicated phenotype and a challenging diagnosis
por: Pagliarani, Serena, et al.
Publicado: (2022)

Editorial: New Insights in Skeletal Muscle Channelopathies - A Rapidly Expanding Field
por: Maggi, Lorenzo, et al.
Publicado: (2020)

Myotonic Dystrophy—A Progeroid Disease?
por: Meinke, Peter, et al.
Publicado: (2018)

Artificial Intelligence and Multiple Sclerosis: Up-to-Date Review
por: Naji, Yahya, et al.
Publicado: (2023)

Current Progress in CNS Imaging of Myotonic Dystrophy
por: Minnerop, Martina, et al.
Publicado: (2018)

TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2
por: Bosè, Francesca, et al.
Publicado: (2019)

Neuronanomedicine: An Up-to-Date Overview
por: Teleanu, Daniel Mihai, et al.
Publicado: (2019)

Autoimmune Diseases in Patients With Myotonic Dystrophy Type 2
por: Peric, Stojan, et al.
Publicado: (2022)

Two Adult Siblings With Myotonic Dystrophy Type 1 With Different Phenotypes Presenting With Chronic Respiratory Insufficiency and Sleep Apnea Syndrome
por: Kohno, Genta, et al.
Publicado: (2019)

Editorial: Myotonic Dystrophies: Developments in Research From Bench to Bedside
por: Silvestri, Gabriella, et al.
Publicado: (2020)

Validation of Motor Outcome Measures in Myotonic Dystrophy Type 2
por: Montagnese, Federica, et al.
Publicado: (2020)

Sleep Disorders in Four Patients With Myotonic Dystrophy Type 1
por: Urata, Yuka, et al.
Publicado: (2020)

Of Mice and Men: Advances in the Understanding of Neuromuscular Aspects of Myotonic Dystrophy
por: Braz, Sandra O., et al.
Publicado: (2018)

Editorial: Beyond Borders: Myotonic Dystrophies–A European Perception
por: Schoser, Benedikt, et al.
Publicado: (2018)

Commentary: Autoimmune diseases in patients with myotonic dystrophy type 2
por: Damen, Manon J., et al.
Publicado: (2022)

Neurotoxicity of Nanomaterials: An Up-to-Date Overview
por: Teleanu, Daniel Mihai, et al.
Publicado: (2019)

Channelopathies
por: Kim, June-Bum
Publicado: (2014)

Multisystemic Impairments in 93 Chinese Patients With Myotonic Dystrophy Type 1
por: Li, Mao, et al.
Publicado: (2020)

Insulin Signaling as a Key Moderator in Myotonic Dystrophy Type 1
por: Nieuwenhuis, Sylvia, et al.
Publicado: (2019)

Genotype-phenotype correlations in pediatric patients with myotonic dystrophy type 1
por: Kim, Hyeong Jung, et al.
Publicado: (2019)

Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy
por: Callus, Edward, et al.
Publicado: (2018)

Flecainide-Induced Brugada Syndrome in a Patient With Skeletal Muscle Sodium Channelopathy: A Case Report With Critical Therapeutical Implications and Review of the Literature
por: Cavalli, Michele, et al.
Publicado: (2018)

Nanomaterials for Wound Dressings: An Up-to-Date Overview
por: Stoica, Alexandra Elena, et al.
Publicado: (2020)

Biomarkers in Multiple Sclerosis: An Up-to-Date Overview
por: Katsavos, Serafeim, et al.
Publicado: (2013)

Transparent Conducting Oxides—An Up-To-Date Overview
por: Stadler, Andreas
Publicado: (2012)

Myotonic Dystrophies: A Genetic Overview
por: Soltanzadeh, Payam
Publicado: (2022)

Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1
por: Alì, Marco, et al.
Publicado: (2020)

Blood-Based Markers of Neuronal Injury in Adult-Onset Myotonic Dystrophy Type 1
por: van der Plas, Ellen, et al.
Publicado: (2022)

Factors Influencing the Severity and Progression of Respiratory Muscle Dysfunction in Myotonic Dystrophy Type 1
por: Hartog, Leigh, et al.
Publicado: (2021)

Editorial: Genotype-Phenotype Correlation in Parkinsonian Conditions
por: Marsili, Luca, et al.
Publicado: (2021)

Genetic neurological channelopathies: molecular genetics and clinical phenotypes
por: Spillane, J, et al.
Publicado: (2016)

Overview of the Complex Relationship between Epigenetics Markers, CTG Repeat Instability and Symptoms in Myotonic Dystrophy Type 1
por: de Pontual, Laure, et al.
Publicado: (2022)

Miller Fisher Syndrome Associated With COVID-19: A Child Case Report and an Up-to-Date Review of the Literature
por: Poyraz, Turan
Publicado: (2023)

Miller Fisher Syndrome Associated With COVID-19: A History of Molecular Mimicry and an Up-to-Date Review of the Literature
por: Poyraz, Turan
Publicado: (2023)

Abnormal Cortical Thickness Is Associated With Deficits in Social Cognition in Patients With Myotonic Dystrophy Type 1
por: Serra, Laura, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a5bhcd4693fr55vbig7t4kov33